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Abstract Expression of the obese (oh) gene is up-regulated in 
the adipose tissue in several obese rodent models. To study the 
regulation of the ob gene expression during the development of 
obesity, we examined the ob gene expression in genetically obese- 
hyperglycemic Wistar fatty (falfa) rats at several stages of obe- 
sity. The ob mRNA levels in the adipose tissue from Wistar fatty 
rats was unequivocally augmented and continued to rise in the 
process of obesity. Furthermore, the ob gene expression in this 
obese model was much more rapidly enhanced in the mesenteric 
fat than in the subcutaneous fat. Moreover, the ob gene expres- 
sion was more greatly augmented in the mesenteric fat than the 
lipoprotein lipase gene expression. These results suggest he pres- 
ence of obesity-linked and region-specific regulation of the ob 
gene expression. 
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1. Introduction 
Obesity is accompanied by complications such as non-insu- 
lin-dependent diabetes mellitus (NIDDM), hyperlipidemia and 
hypertension [1]. Although the molecular mechanisms for obe- 
sity has not been fully elucidated so far, the crucial discovery 
of the obese (ob) gene, the mutation of which results in severe 
obesity in C57BL/6J oblob mice [2], may provide the key to 
clarify the mechanisms underlying obesity. We have isolated rat 
and human ob complementary DNAs (cDNAs) and human ob 
gene [3-5] and demonstrated that the ob gene is expressed in 
the adipose tissue in a region-specific manner [3,4,6]. We also 
showed that the ob gene expression ismarkedly enhanced in the 
adipose tissue in several obese rodent models uch as C57BL/6J 
ob/ob (Shigemoto et al., manuscript in preparation) and C57 
BL/Ks dbldb mice (Ogawa et al., manuscript in preparation), 
Wistar fatty [6] and Zucker fatty rats [3], and rats fed high-fat 
diet [7]. However, the regulation of the ob gene expression in 
the development of obesity is poorly understood. In the present 
study, we examined the alteration of the ob gene expression at 
several stages of obesity in genetically obese-hyperglycemic 
Wistar fatty OCa/fa) rats. Furthermore, since the lipoprotein 
lipase (LPL) plays a crucial role in energy storage and utiliza- 
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tion in the adipose tissue [8,9], we compared the change of the 
ob gene expression with that of the LPL gene in the develop- 
ment of obesity. 
2. Materials and methods 
2.1. Animals and tissue preparation 
Four, 12- and 30-week-old male Wistar fatty (falfa) rats and their 
lean littermates (Fal?) were used in the present study. Blood was sam- 
pled from the tail vein after overnight fasting, and plasma glucose, total 
cholesterol, triglyceride and insulin levels were measured as previously 
reported [10]. After rats were anesthetized with ether inhalation, adi- 
pose tissue was quickly removed, frozen in liquid N2, and stored at 
-80°C until use. White adipose tissue (WAT) was taken from epididy- 
real, mesenteric, subcutaneous abdominal, retroperitoneal f t pads, 
while brown adipose tissue (BAT) was obtained from the interscapular 
fat pad. 
2.2. Total RNA extraction and Northern blot analysis 
Total RNA was extracted as previously described [11]. Northern blot 
analysis was performed [12] using the 32P-labeled rat ob [3] and human 
LPL [8,13] cDNA fragments as probes. 
Autoradiograms were quantitated by densitometric s anning and 
values were normalized to the fl-actin mRNA level to correct for differ- 
ences in the amount of RNA applied. The ob mRNA levels were ex- 
pressed relative to those in the epididymal WAT from Wistar lean rats. 
(The mRNA levels in 10 pg of total RNA from the epididymal WAT 
from Wistar lean rats are defined as 100 unit.) 
2.3. Statistical nalysis 
Data were expressed as the mean+S.D. (Table l) and the 
mean + S.E.M. (Figs. 1 and 2). The statistical significance of differences 
between groups was assessed by Student's unpaired t-test. 
3. Results 
3.1. Profiles of 4-, 12-, and 30-week-old male Wistar fatty rats 
in comparison with their lean littermates 
Table 1 summarizes brief profiles of Wistar fatty rats and 
their lean littermates used in this study. Four-week-old Wistar 
fatty rats were normoglycemic but have already shown signifi- 
cant body weight gain, mild hyperlipidemia and considerable 
hyperinsulinemia. By 12 weeks of age, Wistar fatty rats devel- 
oped marked obesity with hyperglycemia, hypertriglyceridemia 
and hyperinsulinemia as described [6,10]. These values further 
increased at the age of 30 weeks. 
3.2. Augmented expression of the ob gene in Wistar fatty rats 
To elucidate the physiologic and pathophysiologic roles of 
the ob gene, we analyzed the gene expression in the adipose 
tissue from Wistar fatty rats and their lean littermates at the age 
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Fig. 1. The ob mRNA levels in Wistar fatty rats in comparison with their lean littermates at the age of 4, 12 and 30 weeks. The mRNA levels in 
Wistar fatty rats and their lean littermates are indicated by closed and open squares, respectively. Values are mean + S.E.M. (n = 5), *P < 0.001 vs. 
the Wistar lean rats. (A) Epididymal WAT. (B) Mesenteric WAT. (C) Subcutaneous WAT. (D) Retroperitoneal WAT. (E) Interscapular BAT. A 
representative Northern blot analysis of the ob and LPL mRNA is shown in the left panel. F = Wistar fatty rats; L = Wistar lean rats. 
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Fig. 1. (Continued). 
of 4, 12 and 30 weeks. Expression of the ob gene was markedly 
augmented in all the adipose tissue from Wistar fatty rats as 
compared with their lean littermates at all the ages examined 
as shown in Fig. 1. Furthermore, there were regional differ- 
ences in the ob gene expression levels in the adipose tissue from 
Wistar fatty rats. The rank order of the ob mRNA level in 
the adipose tissue was epididymal, retroperitoneal 
WAT > mesenteric and subcutaneous WAT > interscapular 
BAT at the stage of established obesity (12th and 30th week). 
3.3. Continued rise of  the ob gene expression with the advance 
of obesity in Wistar fatty rats 
The ob mRNA levels in all the adipose tissue from Wistar 
fatty rats continued to rise markedly in the process of obesity, 
while the levels of the ob mRNA unaltered or showed a slight 
increase in their lean littermates (Fig. 1). The rank order of the 
fold-increase in the ob mRNA levels from the 4th week to the 
30th week in Wistar fatty rats was mesenteric WAT (12.1) > in- 
terscapular BAT (6.4) > epididymal WAT (5.0) > retroperi- 
toneal WAT (4.8)> subcutaneous WAT (2.8). Since the ob 
gene expression was augmented with maximum fold-increase 
in the mesenteric WAT and with minimum fold-increase in the 
subcutaneous WAT, we focused on the two regions of adipose 
tissue (Fig. 2A). In the mesenteric WAT, the ob mRNA level 
increased with 9.8-fold from the 4th week to the 12th week, and 
1.2-fold from the 12th week to the 30th week. On the other 
hand, in the subcutaneous WAT, the ob mRNA level increased 
with 1.7-fold and 1.6-fold, respectively. 
3.4. Comparison of the change between the ob and LPL mRNA 
levels in the development of obesity 
Since the LPL gene expression i  the adipose tissue has been 
reported to be enhanced in obesity [9,14], we also examined the 
LPL gene expression i the adipose tissue from Wistar fatty rats 
and their lean littermates at the age of 4, 12 and 30 weeks, and 
compared the alteration of the LPL gene expression with that 
of the ob gene expression in the development of obesity. The 
LPL gene expression was also augmented in all the adipose 
tissue examined in Wistar fatty rats at the age of 4, 12 and 30 
weeks as compared with their lean littermates. In Wistar fatty 
rats, the LPL gene expression mildly increased in all the adipose 
tissue examined uring the process of obesity (Figs. 1 and 2). 
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Fig. 2. (A) The ob mRNA levels in the mesenteric and subcutaneous 
WAT from Wistar fatty rats at the age of 4, 12 and 30 weeks. The 
mRNA levels in Wistar fatty rats at the 4th, 12th, and 30th weeks are 
indicated by open, hatched, and closed boxes, respectively. Values are 
mean + SEM of the densitometric measurement of five experiments. 
*P < 0.01 vs. rats at the 4th week, **P < 0.05 vs. rats at the 12th week. 
(B) The LPL mRNA levels in the mesenteric and subcutaneous WAT 
from Wistar fatty rats at the age of 4, 12 and 30 weeks. 
As we demonstrated the regional differences in the fold-in- 
crease of the ob gene expression during the course of obesity 
(maximum fold-increase in the mesenteric WAT and minimum 
fold-increase in the subcutaneous WAT), we compared the 
augmentation of the LPL mRNA levels with those of the ob 
mRNA in the mesenteric and subcutaneous WAT. The fold 
increase in the LPL mRNA levels from the 4th week to the 30th 
week was 2.8 in the mesenteric WAT, while that in the ob 
mRNA levels was 12.1. On the other hand, the LPL mRNA 
increased 1.4-fold in the subcutaneous WAT from the 4th week 
to the 30th week, while the ob mRNA levels were augmented 
2.8-fold (Fig. 2). 
4. Discussion 
The present study demonstrates that the ob mRNA level in 
the adipose tissue from Wistar fatty rats continues to rise mark- 
edly in the process of obesity, while the level of the ob mRNA 
remains unchanged or shows a slight increase in their lean 
littermates. Since body weight increase greatly in Wistar fatty 
rats in the development of obesity, the ob gene expression may 
be regulated by obesity-linked mechanisms such as adipose cell 
size or content of intracellular triglyceride. Alternatively, hu- 
moral factors such as insulin, which also increase greatly during 
the course of obesity, may be responsible for the augmented ob 
gene expression. Further studies are required for the elucida- 
tion of the augmentation of the ob gene expression during the 
development of obesity. 
We also demonstrate the regional specificity in the fold- 
increase of the ob gene expression in Wistar fatty rats (Fig. 2). 
Although the ob mRNA levels in the mesenteric fat were the 
same as those in the subcutaneous fat at the 30th week, the 
fold-increase of the ob mRNA levels from the 4th week to the 
12th week in the mesenteric WAT was 9.8, while that in the 
subcutaneous WAT was 1.7. Funahashi et al. [15] have recently 
shown that the ob gene expression was induced with more rapid 
rate in the mesenteric WAT than in the subcutaneous WAT in 
ventromedial hypothalamus (VMH)-lesioned rats. Together 
with their results, the greater fold-increase of the ob mRNA 
levels in the mesenteric WAT in Wistar fatty rats suggests that 
the ob gene expression is more rapidly enhanced in the mesen- 
teric WAT than in the subcutaneous WAT in the process of 
obesity. Therefore, the ob gene expression may be regulated 
partly by region-specific mechanism. 
In the state of obesity, elevated adipose-tissue LPL synthesis 
has been reported [9,14]. LPL is a rate-limiting enzyme in the 
uptake of free fatty acid into the adipose tissue and plays 
important roles in certain metabolic disorders including obesity 
Table 1 
Profiles of 4-, 12-, and 30-week-old male Wistar fatty rats and their lean 
littermates 
Lean Fatty 
(A) 4 weeks 
Body weight (g) 101.7 + 9.1 131.6 _+ 11.4" 
Glucose (mg/dl) 145 _+ 4 148 + 12 
Triglyceride (mg/dl) 89 + 7 104 + 6* 
Total cholesterol (mg/dl) 99 _+ 7 128 + 17' 
Insulin CuU/ml) 18.2 + 7.0 153.3 + 41.4" 
(B) 12 weeks 
Body weight (g) 384.9 + 0.9 489.9 +_ 18.0" 
Glucose (mg/dl) 127 + 4 381 + 24* 
Triglyceride (mg/dl) 83 + 3 355 + 48* 
Total cholesterol (mg/dl) 107 + 12 126 + 8 
Insulin (~U/ml) 56.6 + 13.0 853.7 + 73.5* 
(C) 30 weeks 
Body weight (g) 452.9 + 20.0 653.8 + 62.8* 
Glucose (mg/dl) 120 +_ 9 379 _+ 28* 
Triglyceride (mg/dl) 85 + 9 380 + 144" 
Total cholesterol (mg/dl) 113 _+ 11 126 _+ 8 
Insulin ~U/ml) 62.3 + 11.1 1083.3 + 168.7" 
Values are maen + S.D. (n = 5), *P < 0.01 vs. the len littermates. 
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[9,13,14]. Therefore, we compared the alteration of the LPL 
gene expression with that of the ob gene expression in the 
process of obesity. The fold-increase ofthe ob mRNA level was 
much greater in the mesenteric WAT from the 4th week to the 
12th week than that of the LPL mRNA level (9.8 vs. 1.2), while 
the ob gene expression was induced in the subcutaneous WAT 
as much as the LPL gene expression (1.7 vs. 1.2). The regulation 
of the ob gene expression i  the mesenteric fat in obesity might 
be different from that of the LPL gene expression. 
In conclusion, the present study demonstrates that the ob 
gene expression i  the adipose tissue from Wistar fatty rats is 
enhanced and continues to rise during the process of obesity. 
The current study also demonstrates the regional specificity in 
the enhancement of he ob gene expression. The ob gene expres- 
sion is more greatly enhanced in the mesenteric WAT than in 
the subcutaneous WAT with the advance of obesity. Further 
studies investigating the mechanisms responsible for the 're- 
gion-specific' regulation of the ob gene expression in the adi- 
pose tissue may provide fresh insight into the pathophysiology 
of obesity. 
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